Nyxoah enrolls first patient in U.S. post-approval Genio study
Go back to Nyxoah enrolls first patient in U.S. post-approval Genio study| (NASDAQ: NYXH) | Delayed: 0.83 -0.06 (6.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.89 | 52 Week High | $ | |||
| Open | $0.85 | 52 Week Low | $ | |||
| Day High | $0.86 | P/E | N/A | |||
| Day Low | $0.81 | EPS | $ | |||
| Volume | 418,452 | |||||



